Bionomics
trial overall conclusions no overall effect on primary of caps total severity score at weeks patients had a greater improvement over placebo than us patients evidence of effect in high dose treatment group in total population trend for effect in high dose treatment group in the total population was well tolerated in patients with be | Bionomics
Company
Deck Type
Sector
Industry
Deck date
April 2022
Slide
33 of 38
Similar slides by Bionomics
See diffirences between slides (animation)
IPO
December 2021
trial overall conclusions teem | Bionomics
Related slides by other companies
Oculis
Investor Presentation
July 2023
study overview | Oculis
Matinas BioPharma
Investor Presentation
February 2024
high unmet medical need in treatment of invasive aspergillosis | Matinas BioPharma
Latham Pool Company
Results
November 2023
fiscal outlook a group swim listed | Latham Pool Company
Matinas BioPharma
Investor Presentation
January 2024
high unmet medical need in treatment of invasive aspergillosis | Matinas BioPharma
Other recent decks by Bionomics
See all presentations (5 decks)
Results
March 2023
Investor Presentation
October 2022
Investor Presentation
June 2022
IPO
December 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io